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NK cells are an important component of the innate immune 
response, as they are rapidly activated upon viral infection and 
can directly recognize infected cells and eliminate them (Vivier 
et al., 2008). Additionally, they can release proinflammatory 
cytokines, which activate other immune cells and facilitate 
the initiation of the adaptive immune response (Vivier et al., 
2008). In particular, their ability to produce IFN-γ during the 
early stages of an infection has been shown to be critical for 
the defense against viral infections (Orange et al., 1995; Thapa 
et al., 2007; Gill et al., 2011). Indeed, the absence of NK cells, 
in Il15−/− mice or through NK cell depletion, results in sig-
nificantly increased susceptibility to HSV-2 infection (Ashkar 
and Rosenthal, 2003; Thapa et al., 2007). Depletion of NK 
cells in mice led to increased HSV-2 viral titers found in the 
vaginal tract, spinal cord, and brain stem (Thapa et al., 2007). 
Further, Ifng−/− mice have increased mortality rates when in-
fected with HSV-2 (Ashkar and Rosenthal, 2003). As a critical 
component of the innate immune response, it is important to 
understand how NK cells are activated, particularly to pro-
duce IFN-γ early in the response.
The functional state of NK cells is greatly influenced 
by their microenvironment. An overwhelming increase 
in activation signals over inhibitory signals will cause acti-
vation of their antiviral functions (Pegram et al., 2011). In 
contrast, a plethora of inhibitory signals will prevent NK cell 
activation (Pegram et al., 2011). Cytokines, including type I 
IFN, IL-15, IL-12, IL-18, and ISG15, have all been shown 
to activate NK cell function, particularly IFN-γ production 
(Pegram et al., 2011). Alternatively, inhibitory receptor recog-
nition of MHC class I on target cells inhibits NK cell activa-
tion (Pegram et al., 2011).
Type I IFNs are central to the activation of NK cells 
during viral infections, including mouse CMV (MCMV), 
adenovirus, vaccinia virus, and HSV infections (Lucas et 
al., 2007; Martinez et al., 2008; Zhu et al., 2008; Gill et al., 
2011; Baranek et al., 2012). Type I IFNs comprise a family 
of cytokines that includes IFN-β and numerous subtypes of 
IFN-α (Platanias, 2005). These cytokines signal through their 
specific receptors, IFN α/β receptor 1 (IFN AR1) and IFN 
AR2, which together form the type I IFN receptor (Platanias, 
2005). Type I IFNs are rapidly produced upon viral infection 
and play an essential role in the antiviral innate immune re-
sponse (Platanias, 2005). Although type I IFNs are required 
for NK cell activation, the underlying mechanism is still con-
the requirement of type I interferon (IFn) for natural killer (nK) cell activation in response to viral infection is known, but the 
underlying mechanism remains unclear. Here, we demonstrate that type I IFn signaling in inflammatory monocytes, but not in 
dendritic cells (dcs) or nK cells, is essential for nK cell function in response to a mucosal herpes simplex virus type 2 (HSV-2) 
infection. Mice deficient in type I IFn signaling, Ifnar−/− and Irf9−/− mice, had significantly lower levels of inflammatory mono-
cytes, were deficient in IL-18 production, and lacked nK cell–derived IFn-γ. depletion of inflammatory monocytes, but not 
dcs or other myeloid cells, resulted in lower levels of IL-18 and a complete abrogation of nK cell function in HSV-2 infection. 
Moreover, this resulted in higher susceptibility to HSV-2 infection. Although Il18−/− mice had normal levels of inflammatory 
monocytes, their nK cells were unresponsive to HSV-2 challenge. this study highlights the importance of type I IFn signaling 
in inflammatory monocytes and the induction of the early innate antiviral response.
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troversial. Evidence in the literature suggests that type I IFNs 
directly activate NK cells during vaccinia virus, adenovirus, 
and lymphocytic choriomeningitis virus infection (Martinez 
et al., 2008; Zhu et al., 2008; Mack et al., 2011). However, 
it has also been reported that type I IFNs act on DCs to 
produce and trans-present IL-15, which leads to NK cell ac-
tivation in response to TLR ligand stimulation and MCMV 
infection (Lucas et al., 2007; Baranek et al., 2012). This sug-
gests that type I IFN signaling is required for IL-15 induction 
after viral infection. However, the majority of studies exam-
ining NK cell activation have used i.v., i.p., or subcutaneous 
routes of viral infection. The mechanism underlying NK cell 
activation during a mucosal infection has yet to be explored.
Inflammatory monocytes (defined by the phenotype 
CCR2+, Ly6Chi) are rapidly recruited to sites of inflammation 
and produce a plethora of inflammatory cytokines to com-
bat infection. Once in the inflammatory environment, these 
inflammatory monocytes can differentiate into DCs, which 
can aid in the development of adaptive immunity against 
infection. However, their role in stimulating innate antiviral 
immunity, particularly NK cell antiviral responses, has been 
relatively unexplored. Depletion of inflammatory monocytes 
from human PBMCs during an in vitro hepatitis C virus 
(HCV) infection suppressed NK cell responses, suggesting 
that these cells are capable of activating NK cells (Zhang et 
al., 2013; Serti et al., 2014).
Here, we describe a thorough mechanism by which NK 
cells are activated during a mucosal viral infection in vivo. 
We clearly show that type I IFN does not directly act on 
NK cells or DCs to activate NK cells. Instead, during vaginal 
HSV-2 infection, type I IFNs signal through inflammatory 
monocytes to produce IL-18, which then activates NK cells 
to produce IFN-γ and augment host defense. 
reSuLtS
IFn Ar and IrF9 are essential for nK cell IFn-γ 
production during HSV-2 infection
Production of IFN-γ by NK cells is the hallmark of the host 
innate immune response to genital HSV-2 infection (Ashkar 
and Rosenthal, 2003; Gill et al., 2011), Indeed, NK cells have 
been shown to be the main producers of IFN-γ during viral 
infections, as in many cases the absence or depletion of these 
cells diminishes IFN-γ production (Krug et al., 2004; Marti-
nez et al., 2008; Zhu et al., 2008; Mack et al., 2011). We first 
confirmed that IFN-γ is produced directly by NK cells in 
response to HSV-2 infection (Fig. 1 A; Gill et al., 2011). De-
pletion of NK cells using anti-NK1.1 or anti–IL-15 antibod-
ies significantly diminished IFN-γ levels in vaginal lavages of 
HSV-2–infected mice (Fig. 1, B and C). We have previously 
shown that IFN AR is required for NK cell IFN-γ produc-
tion during HSV-2 infection (Gill et al., 2011). Production 
of IFN-γ was completely abrogated in Ifnar−/− mice during 
vaginal infection with HSV-2 (Fig. 1 D). This deficiency in 
vaginal IFN-γ level was not a result of decreased NK cell 
recruitment to the vaginal tract (Gill et al., 2011). Addition-
ally, blocking type I IFN receptor in C57BL/6 (B6) mice 
before infection resulted in a complete abrogation of IFN-γ 
production, similar to that observed in genetically deficient 
type I IFN receptor mice (Fig. 1 E). We determined whether 
type I IFNs’ downstream canonical signaling cascade, which 
involves IRF9, is also required for NK cell function during 
infection. There was a complete abrogation of NK cell IFN-γ 
production in the vaginal lavages of HSV-2–infected Irf9−/− 
mice, similar to that observed in Ifnar−/− mice (Fig. 1 F). Ad-
ditionally, the total number of NK cells within the vaginal 
mucosa between WT and Irf9−/− B6 mice was not signifi-
cantly different (Fig. 1 G). This suggests that the deficiency in 
IFN-γ production was not caused by a reduction in vaginal 
NK cell numbers. We also determined that both Ifnar−/− and 
Irf9−/− mice have decreased survival after infection compared 
with WT mice (Fig. 1, H and I). It has been reported that 
levels of vaginal HSV-2 viral replication are proportional to 
the amount of IFN-γ released from NK cells (Gillgrass et al., 
2003). At odds with this finding, we detected similar, if not 
higher, levels of HSV-2 viral replication within the vaginal 
mucosa in Ifnar−/− and Irf9−/− mice compared with WT mice, 
despite a lack of NK cell IFN-γ production in Ifnar−/− and 
Irf9−/− mice (Fig. 1 J). Overall, our data suggest that type I 
IFN signaling is essential for NK cell IFN-γ production. It 
has been shown that IFN-β is rapidly produced in the vaginal 
tract in response to HSV-2 infection or TLR challenge (Gill 
et al., 2006, 2011). IFN-β production occurs at 6 h post-in-
fection (p.i.) and is then down-regulated at 12 and 24 h p.i., 
which would suggest the involvement of IFN-β in activat-
ing NK cell IFN-γ production. However, when Ifnb−/− mice 
were infected with HSV-2, they produced similar amounts of 
IFN-γ compared with WT mice (Fig. 1 K; Gill et al., 2006, 
2011). This would suggest that IFN-β is not essential for acti-
vating NK cells during HSV-2 infection.
expression of IFn Ar on nK cells is not required for their 
activation during HSV-2 infection
After establishing the requirement of type I IFN signaling for 
NK cell function, we inquired whether type I IFN activates 
NK cell IFN-γ production through a direct or indirect mech-
anism. To address this question, we adoptively transferred 
either WT or Ifnar−/− NK cells into Rag2−/−Il2rg−/− mice, 
which lack all lymphocytes including NK cells. In transfer-
ring Ifnar−/− NK cells into these mice, type I IFN signaling 
in the environment is retained, but the adoptively transferred 
NK cells are unable to respond to type I IFN. Upon infection, 
Ifnar−/− NK cells produced IFN-γ in response to HSV-2 in-
fection when transferred to an environment with functional 
type I IFN signaling (Fig. 2 A). In fact, Ifnar−/− NK cells pro-
duced a significantly greater amount of IFN-γ than their WT 
controls, suggesting that IFN AR on NK cells is not required 
for NK cell activation and IFN-γ production (Fig. 2 A). Ad-
ditionally, we were able to detect these adoptively transferred 
cells at day 3 p.i. (Fig. 2 B). As further evidence, we adoptively 
transferred WT NK cells (able to respond to type I IFNs) into 
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Ifnar−/− mice (unable to respond to type I IFNs) and observed 
that WT NK cells in an Ifnar−/− environment were unable to 
produce IFN-γ in response to HSV-2 infection (Fig. 2 C). 
The presence of these adoptively transferred cells persisted in 
the Ifnar−/− mice to day 2 p.i. in both the spleen and vaginal 
mucosa (Fig. 2, D and E).
nK cell activation does not require type I IFn activation  
of dcs or IL-15 trans-presentation
Previously, Lucas et al. (2007) and Baranek et al. (2012) re-
ported that during TLR stimulation and MCMV infection, 
type I IFN stimulates DCs to trans-present IL-15 to NK 
cells and induce their production of IFN-γ. To determine 
whether IFN AR is required on DCs for the subsequent 
activation of NK cells during a mucosal vaginal infection, 
we used a mouse model wherein only DCs are deficient in 
IFN AR. As detailed in Diamond et al. (2011), we crossed 
Ifnarf/f mice with CD11c-Cre+ transgenic mice to gener-
ate offspring that are selectively IFN AR deficient in DCs. 
No IFN AR-expressing CD11c+ DCs could be identified 
by flow cytometry in these mice (not depicted). Infection 
of these mice yielded no significant difference in vagi-
nal NK cell IFN-γ production in comparison to controls, 
suggesting that DCs are not required to induce NK cell 
IFN-γ production (Fig. 3 A). To determine whether IL-15 
trans-presentation is involved in the activation of NK cells 
Figure 1. type I IFn receptor and its respective signaling through IrF9 is required for nK cell IFn-γ production during HSV-2 infection. (A) WT 
B6 mice were infected with 104 pfu HSV-2 intravaginally (ivag). On day 2 p.i., vaginal tracts were processed and examined for NKp46, CD3, and IFN-γ ex-
pression. (B) WT B6 mice were depleted of NK cells using anti-NK1.1 antibody or IL-15 using anti–IL-15 antibody and then infected with 104 pfu HSV-2 ivag. 
Day 1–3 p.i. vaginal lavages were examined for IFN-γ levels (n = 5). (C) Peripheral blood was examined for NK cells in mice given anti–IL-15 antibody (n = 5). 
(D) WT and Ifnar−/− mice were infected with 104 pfu HSV-2 ivag, and vaginal lavages were examined for IFN-γ production on days 1–3 p.i. (n = 3; repeated 
twice with similar results). (E) WT B6 mice were administered anti-IFN AR antibody or the respective isotype-matched control Ig on days −1 through 2 i.p. 
and then infected with 104 pfu HSV-2 ivag. Their vaginal lavages were examined for IFN-γ content (n = 4; repeated once with similar results). (F) WT and 
Irf9−/− mice were infected with 104 pfu HSV-2 ivag, and vaginal lavages were examined for IFN-γ levels on days 1–3 p.i. (n = 3; repeated once with similar 
results). (G) WT and Irf9−/− mice were infected with 104 pfu HSV-2 ivag. At day 3 p.i., the vaginal mucosa was examined for CD3-NK1.1+ NK cells (n = 3; 
repeated once with similar results). (H) WT, Ifnar−/−, and Irf9−/− mice were infected with 104 pfu HSV-2 ivag and followed for survival (n = 5; repeated once 
with similar results). (I) WT mice were administered anti-IFN AR antibody or the respective isotype control Ig on days −1 through 2 and infected with 104 
pfu HSV-2 ivag. Mice were followed for survival (n = 4). (J) After infection with HSV-2, vaginal lavages were collected from WT, Ifnar−/−, and Irf9−/− mice and 
assessed for HSV-2 level via plaque assay (n = 5). (K) WT and Ifnb−/− mice were infected with 104 pfu HSV-2 ivag. Day 1-3 vaginal washes were collected 
and examined for IFN-γ amount (n = 4). Data in B, D–F, and K are displayed as mean ± SEM and were analyzed using two-way ANO VA: n.s., not significant; 
***, P < 0.001; ****, P < 0.0001. Data in C and G are displayed as mean ± SEM and were analyzed using an unpaired Student’s t test and a Mann–Whitney 
test (for nonparametric data), respectively: n.s., not significant; **, P < 0.01. Data in J are displayed as mean ± SEM and were analyzed using one-way ANO 
VA. Data in H and I were analyzed using a log-rank test: *, P < 0.05; **, P < 0.01.
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during HSV-2 infection, we provided Ifnar−/− and WT 
mice with a trans-presentation mimic, IL-15 in complex 
with its specific receptor α (Rα), in an attempt to rescue 
NK cell IFN-γ production in Ifnar−/− mice. IL-15/IL-
15Rα complexes (IL-15/Rα) have been shown to induce 
rapid proliferation as well as induction of IFN-γ produc-
tion in NK cells (Elpek et al., 2010). However, we were 
unable to rescue IFN-γ production in Ifnar−/− mice, despite 
finding NK cell proliferation in both the spleen and vag-
inal tract (Fig. 3, B–F). Significant increases in proportion 
of NK cells were observed in the spleen. Thus, IL-15/Ra 
complexes were sufficient to stimulate NK cell prolifera-
tion, but not IFN-γ production.
IL-18 is required for nK cell IFn-γ 
production during HSV-2 infection
Several factors, including IL-15, IL-12, ISG15, and IL-18, 
have been shown to induce NK cell IFN-γ production, 
particularly during viral infection (Pegram et al., 2011). We 
have determined that IL-15 is not sufficient to activate NK 
cells during genital HSV-2 infection (Fig. 3 B). Further, we 
previously reported that Ifnar−/− mice can produce IL-15 in 
the vaginal mucosa after genital HSV-2 infection (Gill et al., 
2011). IL-12 is a well-known activator of IFN-γ production, 
but we have previously shown that HSV-2 infection of IL-
12−/− mice had no impact on IFN-γ production by NK cells 
(Gill et al., 2011). Here, we examined the role of ISG15 in 
Figure 2. IFn Ar is not required directly on nK cells to activate their IFn-γ production. (A) NK cells were isolated from WT or Ifnar−/− spleens and 
adoptively transferred into Rag2−/−Il2rg−/− mice i.v. 24 h after transfer, mice were infected with 104 pfu HSV-2 ivag, and on days 1–3, vaginal lavages were 
examined for IFN-γ levels (n = 3; repeated twice with similar results). (B) Spleens were collected on day 3 p.i. and analyzed for DX5 expression. (C) NK cells 
were isolated from WT spleens, CFSE-labeled, and then adoptively transferred into Ifnar−/− mice. 24 h after transfer, Ifnar−/− mice given WT NK cells, and WT 
controls were infected with 104 pfu HSV-2 ivag. Day 1–3 p.i. vaginal lavages were examined for IFN-γ content (n = 3; repeated once with similar results). 
(D) Spleens were examined for CFSE+NK1.1+ adoptively transferred cells on days 1 and 2 p.i. (representative of two independent experiments). (E) Vaginal 
tissue from Ifnar−/− mice with or without adoptive transfer of CFSE-labeled NK cells was examined on day 2 p.i. for CFSE+NK1.1+ cells (representative of two 
independent experiments). Vaginal cells were first gated on the CD45+CD3−NK1.1+ population and then examined for CFSE expression. Data in A and C are 
displayed as mean ± SEM and were analyzed using two-way ANO VA: *, P < 0.05; **, P < 0.01; ***, P < 0.001.
 o
n






1157JEM Vol. 214, No. 4
Figure 3. cd11c+ cells are not required to respond to type I IFn or trans-present IL-15 during the activation of nK cell IFn-γ production during 
infection. (A) Ifnarf/f and Ifnarf/f Itgax-cre mice were infected with 104 pfu HSV-2 ivag and examined for IFN-γ in the vaginal lavages collected days 1–3 p.i. 
(n = 5; repeated once with similar results). (B) WT and Ifnar−/− mice were given 0.5 µg IL-15 in complex with 1 µg IL-15Rα i.p. and subsequently infected with 
5 × 104 pfu HSV-2 ivag on the same day. Vaginal washes were collected on days 1–3 p.i. and examined for IFN-γ levels (n = 4; repeated once with similar 
results). (C and D) Spleen (C; n = 3) and vaginal (D; n = 2) tissue were collected on day 3 p.i. and examined for CD45+CD3−NK1.1+ NK cells as shown in the 
representative flow plots. (E and F) Flow data are quantitatively shown for spleen (E) and vaginal mucosa (F). Data in A, B, E, and F are displayed as mean 
± SEM and were analyzed using two-way ANO VA: n.s., not significant; ***, P < 0.001; ****, P < 0.0001.
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the activation of NK cells, as human ISG15 deficiency has 
been observed to lead to decreased NK cell IFN-γ produc-
tion during mycobacterial infection (Bogunovic et al., 2012). 
HSV-2 infection of Isg15−/− mice yielded no difference in 
NK cell IFN-γ production in comparison to WT mice (not 
depicted). We investigated whether IL-18 is required for NK 
cell activation in response to HSV-2 infection. We first com-
pared IL-18 content in the vaginal lavages of Ifnar−/− and WT 
B6 mice and detected significantly lower levels of IL-18 in 
Ifnar−/− vaginal lavages, particularly at day 2 p.i. (Fig. 4 A). To 
further investigate the role of IL-18 in the induction of IFN-γ 
production by NK cells, we infected mice that lacked IL-18 or 
IL-18R. There was a significant abrogation in the production 
of IFN-γ by NK cells in both Il18−/− and Il18r1−/− mice in-
fected with HSV-2 compared with WT mice (Fig. 4 B). This 
decrease was not caused by a lack of NK cell recruitment to 
the vaginal mucosa in Il18−/− or Il18ra−/− mice (Fig. 4, C and 
D). These data demonstrate that IL-18 is required for the acti-
vation of NK cell IFN-γ production during HSV-2 infection.
nK cells respond to IL-18 directly to produce IFn-γ
To investigate whether IL-18 directly activates NK cells, we 
adoptively transferred either Il18ra−/− or WT B6 NK cells 
into Rag2−/−Il2rg−/− mice before infection with HSV-2. 
After infection, Il18r1−/− NK cells adoptively transferred 
to Rag2−/−Il2rg−/− mice had significantly decreased IFN-γ 
production compared with WT NK cells (Fig. 4 E). How-
ever, Il18r1−/− NK cells produced copious amounts of IFN-γ 
when stimulated with PMA and ionomycin (Fig. 4 F). These 
findings suggest that Il18r1−/− NK cells are not inherently 
incapable of producing IFN-γ but lack the required signaling 
via IL-18R to do so during HSV-2 infection.
Hematopoietic cells respond to type I IFn and produce 
IL-18 to activate nK cells
Because our data have clearly indicated that type I IFNs are 
required but do not act directly on NK cells, we investigated 
for the cell types that produce IL-18 in response to type I 
IFN. We first used bone marrow chimeric mice to determine 
whether hematopoietic or nonhematopoietic cells were re-
quired. We created chimeric mice by reconstituting WT and 
Ifnar−/− mice with either WT or Ifnar−/− bone marrow and 
examined reconstitution in the peripheral blood (Fig. 5 A). 
After HSV-2 infection, WT recipients reconstituted with 
Ifnar−/− bone marrow were unable to produce IFN-γ at days 
2 and 3 p.i., whereas Ifnar−/− recipients reconstituted with 
WT bone marrow did produce IFN-γ (Fig. 5 B). To deter-
mine whether the hematopoietic cell compartment is also re-
Figure 4. IL-18 and IL-18r are both required for nK cell IFn-γ production during HSV-2 infection. (A) WT and Ifnar−/− mice were infected with 
104 pfu HSV-2 ivag, and day 1–3 vaginal lavages were examined for IL-18. Data were normalized to Il18−/− data (n = 5; repeated once with similar results). 
(B) WT, Il18−/−, and Il18r1−/− B6 mice were infected with 104 pfu HSV-2 ivag, and on day 1–3 p.i. vaginal lavages were examined for IFN-γ content (n = 5; 
repeated once with similar results). (C and D) Vaginal tissue was isolated on day 3 p.i. and examined for CD45+CD3−NK1.1+ cells in Il18−/− (C; n = 3) and 
Il18r1−/− (D; n = 3) mice. (E) WT and Il18r1−/− NK cells were isolated from the spleen and adoptively transferred into Rag2−/−Il2rg−/− mice i.v. 24 h p.i. The 
mice were infected with 104 pfu HSV-2 ivag. On days 1–3 p.i., vaginal lavages were collected and examined for IFN-γ (n = 6). (F) NK cells were isolated from 
WT, Ifnar−/−, and Il18r−/− spleens and stimulated with 50 ng/ml PMA and 500 ng/ml ionomycin for 24 h ex vivo. Supernatants were collected and assayed 
for IFN-γ (n = 3). Data in A, B, and E are displayed as mean ± SEM and were analyzed using two-way ANO VA: *, P < 0.05; **, P < 0.01; ****, P < 0.0001. Data 
in C and D are displayed as mean ± SEM and were analyzed using an unpaired Student’s t test: n.s., not significant. Data in F are displayed as mean ± SEM 
and were analyzed using one-way ANO VA: n.s., not significant.
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quired to produce IL-18, we created bone marrow chimeric 
mice between WT and Il18−/− mice and examined recon-
stitution in the peripheral blood (Fig. 5 C). Upon infection 
with HSV-2, NK cells from Il18−/− mice that received WT 
bone marrow produced IFN-γ, whereas WT mice reconsti-
tuted with Il18−/− bone marrow did not (Fig. 5 D). These 
data suggest that the cells responding to type I IFN, as well 
as producing IL-18, belong to the hematopoietic cell com-
partment. Furthermore, this intermediary cell type is likely 
of myeloid lineage, as Rag2−/−Il2rg−/− mice are alymphoid, 
yet the transfer of WT or Ifnar−/− NK cells into these mice 
yielded IFN-γ production (Fig. 2 A).
decreased vaginal recruitment of inflammatory 
monocytes in Ifnar−/− mice
It has been documented that macrophages can activate NK 
cells during infection (Hamerman et al., 2004; Sirén et al., 
2004). However, we found that depletion of macrophages by 
clodronate administration had no impact on NK cell IFN-γ 
production during HSV-2 infection (not depicted). Eosino-
phils are a cell type prominent within the reproductive tract 
and may play a role against infection (Robertson et al., 2000). 
However, similar to macrophages, we found no difference 
in vaginal NK cell production of IFN-γ between Gata1−/− 
mice, which lack eosinophils, and WT controls (not depicted). 
When we compared the composition of myeloid immune 
cells within the vaginal mucosa between WT and Ifnar−/− 
mice during infection, we observed significantly decreased 
recruitment of inflammatory monocytes in Ifnar−/− mice on 
both days 2 and 3 p.i. (Fig. 6, A and B). In agreement with 
this, we also found that Ifnar−/− mice had significantly de-
creased vaginal content of MCP-1, the chemokine responsi-
ble for recruiting inflammatory monocytes, during infection 
(Fig. 6 C). In contrast, there was no significant difference in 
Figure 5. the hematopoietic cell compartment is required to respond to type I IFn and produce IL-18 to activate IFn-γ production during 
HSV-2 infection. (A) WT and Ifnar−/− mice were lethally irradiated and reconstituted with either WT or Ifnar−/− bone marrow. Mice were allowed to recon-
stitute for 6–8 wk, and peripheral blood was assessed for reconstitution by examining the frequency of cells expressing CD45.1 or CD45.2. (B) Mice were 
then infected with 5 × 104 pfu HSV-2 ivag. On days 1–3 p.i., vaginal lavages were examined for IFN-γ content (n = 3; repeated once with similar results). 
(C) WT and Il18−/− mice were lethally irradiated and reconstituted with either WT or Il18−/− bone marrow. 6–8 wk after reconstitution, mice were examined 
for CD45.1 and CD45.2 expression. (D) Mice were then infected with 104 pfu HSV-2 ivag. On days 1–3 p.i., vaginal lavages were examined for IFN-γ (n = 7). 
Data in B and D are displayed as mean ± SEM and were analyzed using two-way ANO VA: ****, P < 0.0001.
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MCP-1 levels and inflammatory monocyte recruitment in 
Il18−/− mice compared with WT mice on days 2 and 3 p.i. 
(Fig. 6, A, D, and E).
Inflammatory monocytes, but not neutrophils, are essential 
for nK cell IFn-γ production
Because the recruitment of inflammatory monocytes is signifi-
cantly reduced in Ifnar−/− mice, we examined whether these 
cells were involved in activating NK cells during infection. 
Initially, we depleted both inflammatory monocytes and neu-
trophils using the anti–GR-1 depletion antibody RB6-8C5 
in WT mice before infection with HSV-2 (Fig. 7, A–D; Daley 
et al., 2008). This led to a drastic reduction in NK cell IFN-γ 
production, with no impact on NK cell recruitment to the 
vaginal tissue or proportion of vaginal CD11c+ cells during 
infection (Fig.  7, E–G). To assess the role of inflammatory 
monocytes, we used a recently developed anti-CCR2 anti-
body that has been shown to successfully deplete inflamma-
tory monocytes while leaving the neutrophil cell population 
intact (Mack et al., 2001; Schumak et al., 2015). This anti-
body depleted the inflammatory monocyte population in the 
vaginal mucosa without impacting the neutrophil population 
during infection (Fig. 8, A–D). In the absence of inflamma-
tory monocytes, there was an almost complete abrogation of 
IFN-γ production by NK cells within the vaginal mucosa, 
while the percentage of NK cells and CD11c+ cells in the 
vaginal mucosa during infection were similar (Fig. 8, E–G). 
Furthermore, when we examined vaginal HSV-2 viral titers in 
the absence of inflammatory monocytes, we found that there 
was a significant increase in HSV-2 viral titer level compared 
with mice given an isotype-matched control Ig (Fig. 8 H). 
This suggests that inflammatory monocytes are essential in 
Figure 6. decreased vaginal inflammatory monocyte infiltration in Ifnar−/− mice during HSV-2 infection. (A) WT, Ifnar−/−, and Il18−/− mice were 
infected with 104 pfu HSV-2, and vaginal tissue was collected at baseline and on days 0–3 p.i. and examined for inflammatory monocytes, defined as 
CD45+CD11c−CD11b+Ly6G−Ly6ChiCCR2+ cells. Day 2 and 3 p.i. data are shown in representative flow plots. (B) Flow cytometry data were quantified and 
graphically represented (n = 3; repeated once with similar results). (C) Vaginal lavages were collected on days 0–3 p.i. and examined for MCP-1 (n = 3; 
repeated once with similar results). (D) WT and Il18−/− mice were infected with HSV-2 ivag, and vaginal tissue was collected at baseline and on days 2 and 3 
p.i. and examined for inflammatory monocytes (n = 3). (E) WT and Il18−/− mice were infected with 104 pfu HSV-2 ivag, and on days 0–3 p.i., vaginal lavages 
were examined for MCP-1 (n = 4). Data in B–E are displayed as mean ± SEM and were analyzed using two-way ANO VA: **, P < 0.01; ***, P < 0.001.
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activating NK cell IFN-γ production, which is necessary for 
controlling HSV-2 infection in the innate immune response.
depletion of inflammatory monocytes abrogates IL-18 
production during HSV-2 infection
To determine whether inflammatory monocytes are respon-
sible for producing IL-18 during vaginal HSV-2 infection, we 
examined IL-18 levels in the vaginal lavages of mice depleted 
of inflammatory monocytes. Compared with mice given 
an isotype-matched control Ig, mice given the anti-CCR2 
antibody had significantly decreased IL-18 content in their 
vaginal lavages, particularly on days 2 and 3 p.i. (Fig. 8 I). We 
have previously published that Ifnar−/− mice have significantly 
lower levels of vaginal IL-12 at days 2 and 3 p.i. compared with 
Figure 7. Inflammatory monocytes are required for activating nK cell IFn-γ production during HSV-2 infection. (A and B) WT B6 mice were 
given an anti–GR-1 antibody or its respective isotype-matched control Ig and infected with 104 pfu HSV-2 ivag. Vaginal tissue was examined for neutrophil 
(CD45+CD11c−CD11b+Ly6G+) and inflammatory monocyte (CD45+CD11c−CD11b+Ly6G−Ly6ChiCCR2+) depletion on day 3 p.i. Representative flow plots of vag-
inal neutrophil and inflammatory monocyte populations are shown (respectively in A and B). (C and D) Vaginal neutrophil (C) and inflammatory monocyte 
(D) populations are displayed graphically (n = 5; repeated once with similar results). (E) On days 1–3 p.i., vaginal washes were examined for IFN-γ (n = 5; 
repeated twice with similar results). (F and G) Vaginal tissue collected on day 3 p.i. was also examined for total vaginal NK cell number (F; CD45+CD3−NK1.1+; 
n = 5) and proportion of CD11c+ cells (G; CD45+CD11c+; n = 5; repeated once with similar results). Data in C, D, F, and G are displayed as mean ± SEM and 
were analyzed using an unpaired Student’s t test in D and G and a Mann–Whitney test (for nonparametric data) in C and F: n.s., not significant; **, P < 0.01; 
***, P < 0.001. Data in E are displayed as mean ± SEM and were analyzed using two-way ANO VA: ****, P < 0.0001.
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WT mice (Gill et al., 2011). We examined whether deple-
tion of inflammatory monocytes impacted induction of IL-12 
during HSV-2 infection. Upon depletion of inflammatory 
monocytes, however, we observed no significant difference in 
levels of IL-12 (Fig. 8 J). Overall, these data suggest that in-
flammatory monocytes are responsible for IL-18, but not IL-
12, production in the vaginal mucosa during HSV-2 infection.
dIScuSSIon
Early IFN-γ production from NK cells is the hallmark of 
the innate immune response and is required for protection 
during vaginal HSV-2 infection (Ashkar and Rosenthal, 2003; 
Gill et al., 2011). We and others have found that the presence 
of IFN AR is absolutely required for the activation of IFN-γ 
production by NK cells (Lucas et al., 2007; Martinez et al., 
Figure 8. Inflammatory monocytes are required for activation of nK cell IFn-γ production during infection. (A–D) WT B6 mice were given an 
anti-CCR2 antibody or the respective isotype-matched control Ig to deplete inflammatory monocytes and then infected with 104 pfu HSV-2 ivag. Vaginal 
tissue was collected on day 3 p.i. and examined for neutrophil and inflammatory monocyte populations. Representative flow plots are respectively shown 
in A and B and graphically in C and D (n = 5). (E and F) On day 3 p.i., vaginal cells were also examined for NK cells (E; n = 5) and CD11c+ cells (F; n = 5). 
(G) On days 0–3 p.i., vaginal lavages were examined for IFN-γ levels (n = 4; repeated once with similar results). (H) On day 2 p.i., vaginal washes were exam-
ined for HSV-2 viral titers using a plaque assay method (n = 4; repeated once with similar results). (I and J) Day 0–3 p.i. vaginal lavages were also examined 
for IL-18 levels (I; n = 4; repeated once with similar results) and IL-12 levels (J; n = 5). Data in C–F and H are displayed as mean ± SEM and were analyzed 
using an unpaired Student’s t test in F and a Mann-Whitney test (for nonparametric data) in C–E and H: n.s., not significant; *, P < 0.05; **, P < 0.01. Data 
in G, I, and J are displayed as mean ± SEM and were analyzed using two-way ANO VA: *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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2008; Zhu et al., 2008; Gill et al., 2011; Baranek et al., 2012). 
Here, we demonstrate a mechanism by which type I IFN 
activates IFN-γ production by NK cells during a mucosal 
viral infection. Although IFN AR is not required on NK cells 
for their activation, we have also determined that type I IFN 
does not go through the canonical pathway of DC activation 
and IL-15 trans-presentation in our model (Lucas et al., 2007; 
Baranek et al., 2012). Instead, type I IFN is necessary to recruit 
inflammatory monocytes, as well as signal through these cells, 
to release IL-18, which then acts directly on NK cells through 
their IL-18R to induce their production of IFN-γ (Fig. 9).
Previously, several studies have suggested that type 
I IFN signals directly on NK cells to induce their activation 
(Martinez et al., 2008; Zhu et al., 2008; Mack et al., 2011). 
Through our adoptive transfer system, we found that NK 
cells do not require IFN AR expression to become activated 
to produce IFN-γ during HSV-2 infection. This is similar to 
previously published results by Guan et al. (2014) in which 
they demonstrated that IFN AR was not required on NK 
cells for their activation in the context of MCMV infection. 
Surprisingly, our results showed that Ifnar−/− NK cells have 
increased expression of IFN-γ when adoptively transferred 
to Rag2−/−Il2rg−/− mice compared with WT NK cells. Type I 
IFN has been shown to negatively regulate IFN-γ production 
from NK cells, explaining the increase in IFN-γ expression 
from Ifnar−/− NK cells (Nguyen et al., 2000; Teles et al., 2013). 
On the other hand, Lucas et al. (2007) and Baranek et al. 
(2012) reported that type I IFN stimulates DCs to trans-pres-
ent IL-15, which in turn activates NK cells (Lucas et al., 2007; 
Baranek et al., 2012). However, we found the mucosal route 
involves inflammatory monocytes and IL-18, rather than DCs 
and IL-15 trans-presentation. This is supported by previous 
evidence showing that IL-15 production in the vaginal mu-
cosa of Ifnar−/− mice is similar to, if not higher than, that of 
WT mice during HSV-2 infection (Gill et al., 2011). Fur-
thermore, we found similar amounts of NK cell IFN-γ pro-
duction in mice that had a specific absence of IFN AR on 
CD11c+ cells versus WT controls, indicating that DCs were 
not responsible for responding to type I IFN. Additionally, 
administration of IL-15–IL-15 receptor complexes, although 
leading to significant NK cell proliferation, did not rescue 
NK cell IFN-γ production in Ifnar−/− mice. The difference in 
findings may lie in the route of viral infection, which involves 
infecting through a mucosal surface, the vaginal mucosa. The 
majority of articles examining the relationship between type 
I IFN and NK cell activation administer viral infection or 
TLR stimulants through in vitro or systemic, i.p., or subcuta-
neous routes of infection and found contradicting outcomes 
(Lucas et al., 2007; Martinez et al., 2008; Zhu et al., 2008; 
Baranek et al., 2012). Although we observed a decrease in 
IFN-γ production in WT mice after administration of IL-15/
IL-15Rα, it is known that IL-15 is able to reduce HSV-2 
virus replication both in vivo and in vitro independently of 
its effects on NK cells. Because NK cell IFN-γ production is 
correlated with HSV-2 replication, IL-15’s ability to reduce 
HSV-2 viral titers subsequently reduces IFN-γ expression 
from NK cells (Gill et al., 2005).
IFN-β and numerous subtypes of IFN-α have both 
been shown to signal through the type I IFN receptor and 
are produced upon virus infection (Perry et al., 2005). Indeed, 
Gill et al. (2011) have previously shown that vaginal HSV-2 
infection rapidly induces IFN-β production at 6 h p.i. but is 
rapidly controlled at 12 and 24 h p.i. Because IFN-β is pro-
duced early during HSV-2 infection, we were interested in 
Figure 9. type I IFn activates nK cell 
IFn-γ production through the stimula-
tion of IL-18 production in inflammatory 
monocytes during vaginal HSV-2 infec-
tion. Rapidly after HSV-2 infection, type I IFN 
is produced in the vaginal mucosa. Type I IFN 
induces CCL2 production from a cell type or 
types and recruits inflammatory monocytes to 
the site of infection. Type I IFN binds IFN AR on 
inflammatory monocytes and signals through 
IRF9 to induce their release of IL-18. IL-18 
then ligates to IL-18R on NK cells to induce 
their production of IFN-γ.
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determining the role of IFN-β in activating NK cells. How-
ever, we found that IFNβ−/− mice had comparable levels of 
IFN-β production to WT mice. It is likely that IFN-α is able 
to compensate for the absence of IFN-β.
During vaginal HSV-2 infection, we observed that DCs 
were not required to respond to IFN AR, but instead, inflam-
matory monocytes were necessary for the activation of NK 
cell IFN-γ production. In agreement with Iijima et al. (2011), 
we found that Ifnar−/− mice had decreased MCP-1 produc-
tion and a reduction in inflammatory monocyte recruitment 
during HSV-2 infection. They also showed that type I IFN 
induced CCR2 ligand production (MCP-1, CCL7, CCL8, 
and CCL12), which was ultimately responsible for inflam-
matory monocyte recruitment (Iijima et al., 2011). When we 
depleted inflammatory monocytes using an anti-CCR2 anti-
body, we observed a complete abrogation of NK cell IFN-γ 
production. However, Iijima et al. (2011) also observed that 
Ccr2−/− mice, which have significant deficiencies in inflam-
matory monocyte recruitment, also had decreased NK cell 
IFN-γ production. Although they found that CCR2 was re-
quired for NK cell recruitment to the vaginal mucosa, our 
depletion of inflammatory monocytes did not impact NK 
cell recruitment to the vaginal mucosa (Iijima et al., 2011). 
Furthermore, we did not observe any difference in propor-
tion of CD11c+ cells in the vaginal mucosa when depleting 
inflammatory monocytes. We also found that depletion of 
inflammatory monocytes increased vaginal HSV-2 viral titer 
levels at day 2 p.i., suggesting that inflammatory monocyte 
activation of NK cell IFN-γ production is critical for limiting 
HSV-2 virus replication during the early stages of infection. 
In humans, depletion of monocytes from PBMCs in an in 
vitro model of HCV infection reduced NK cell IFN-γ pro-
duction (Zhang et al., 2013; Serti et al., 2014). In particu-
lar, Serti et al. (2014) observed that monocyte production of 
IL-18 was responsible for activating the NK cells.
IL-18 is a well-known cytokine activator of NK cell 
IFN-γ production (Okamura et al., 1995). Interestingly, like 
IL-1β, IL-18 is first produced intracellularly as an immature 
protein without a signal peptide and, in this form, is con-
stitutively expressed (Dinarello et al., 2013). To be secreted, 
the IL-18 precursor needs to be cleaved into a mature and 
bioactive protein, usually by caspase-1 (Dinarello et al., 2013). 
Once secreted from the cell, IL-18 can bind to its two specific 
receptors, IL-18α and IL-18β, and cause signal transduction 
through MyD88 within the receiving cell (Dinarello et al., 
2013). During mucosal HSV-2 infection, Il18−/− mice have 
significantly increased shedding of HSV-2 in their vaginal 
washes and decreased survival when compared with control 
mice (Harandi et al., 2001). Accordingly, we found that type 
I IFN–induced IL-18 production was a critical factor for NK 
cell activation. Similar to our findings, others have shown that 
a deficiency in IL-18 production leads to decreased NK cell 
IFN-γ production in vivo during vaccinia virus, Francisella 
tularensis, and Chlamydia muridarum infections (Nagarajan 
et al., 2011; Pierini et al., 2013; Brandstadter et al., 2014). 
Even when using a natural mouse pathogen, orthopoxvi-
rus ECTV, Il18−/− mice produced significantly less NK cell 
IFN-γ (Wang et al., 2009). Using an i.v. HSV-1 infection 
model, Barr et al. (2007) observed that IL-18 production by 
CD11c+ cells was responsible for IFN-γ production by NK 
cells in an ex vivo splenocyte culture.
Much of the data regarding the relationship between 
type I IFN and IL-18 suggests that type I IFN activates cleav-
ing of pro–IL-18 into active IL-18 (Fernandes-Alnemri et al., 
2010; Fang et al., 2014). Recently, Fang et al. (2014) observed 
that type I IFN produced during Streptococcus pneumoniae 
infection led to IL-18 production through the activation of 
caspase-1. During F. tularensis infection, Fernandes-Alnemri 
et al. (2010) observed that Ifnar−/− mice were defective in 
their ability to induce caspase-1 activation, which in turn 
inhibited their ability to cleave pro–IL-18 into active IL-18 
(Fernandes-Alnemri et al., 2010). They attributed this to the 
ability of type I IFN to activate the absent in melanoma 2 
(AIM2) inflammasome complex, which is responsible for ac-
tivating caspase-1 (Fernandes-Alnemri et al., 2010). Further 
studies will be required to determine whether a similar mech-
anism occurs during viral infection and NK cell activation.
Our findings provide a complete mechanism detail-
ing the steps that type I IFN takes to activate NK cells. Type 
I IFN produced during a viral infection stimulates MCP-1 
production, which is responsible for inflammatory mono-
cyte migration to the site of inflammation. Once recruited, 
type I IFN stimulates inflammatory monocytes to produce 
IL-18, which then signals through the IL-18R expressed by 
NK cells to induce their production of IFN-γ. In under-
standing the mechanism of NK cell activation during muco-
sal vaginal HSV-2 infection, this information can be applied 
to other infections, cancers, and ailments that involve IL-18 
and the activation of NK cells. Moreover, this information 




6–8-wk-old C57BL/6 (B6) mice were purchased from 
Charles River. Il18−/− and Il18r1−/− mice on a B6 back-
ground were purchased from The Jackson Laboratory. 
Breeding pairs of Ifnar−/− mice on a B6 background were 
provided by L. Lenz (University of Colorado, Boulder, CO) 
and then bred at McMaster University’s Central Animal 
Facility (CAF). Breeding pairs of Rag2−/−Il2rg−/− mice 
on a BALB/c background were provided by M. Ito (Cen-
tral Institute for Experimental Animals, Kawasaki, Japan) 
and then bred in our CAF. Breeding pairs of Irf9−/− mice 
were provided by T. Taniguchi (University of Tokyo, Tokyo, 
Japan) to K.L. Mossman, and a colony was established at 
McMaster’s CAF. Breeding pairs of Gata1−/− mice on a B6 
background were established in M. Jordana’s laboratory at 
McMaster’s CAF. Ifnb−/− mice on a B6 background were 
generously provided by E.N. Fish (University of Toronto, 
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Toronto, ON, Canada). Isg15−/− mice were generously pro-
vided by P. Gros (McGill University, Montreal, QC, Canada). 
Ifnarf/f Itgax-cre+ and Ifnarf/f control mice were provided by 
R.D. Schreiber and bred in our CAF. All mice were housed 
in specific pathogen–free conditions with a 12-h day and 
12-h night cycle. All experiments were performed in ac-
cordance with Canadian Council on Animal Care guide-
lines and approved by the Animal Research Ethics Board 
at McMaster University.
Genital HSV-2 infection
Mice were injected subcutaneously with 2 mg Depo-Provera 
(medroxyprogesterone acetate) 5 d before HSV-2 infection. 
Mice were then infected with HSV-2, 333 strain, and assessed 
for genital pathology and survival. Genital pathology was 
scored on a scale of 5 according to severity of redness, swell-
ing, lesion development, hair loss, ulceration, and lower limb 
paralysis. Ulceration of a lesion and/or lower limb paralysis 
was considered endpoint.
Vaginal viral titration
Vero cells were grown in a monolayer to confluence in 12-
well plates in α-MEM supplemented with 1% (vol/vol) 
each of l-glutamine, penicillin and streptomycin, and Hepes. 
Vaginal lavages were serially diluted and incubated with the 
monolayer for 2  h. The vero cells were then overlaid with 
human immune serum containing α-MEM and subsequently 
incubated for 48 h. After incubation, the cells were fixed and 
stained with crystal violet, and plaques were quantified using 
an inverted microscope.
Vaginal lavages
During days 0–3 p.i., vaginal lavages were performed by 
flushing the vaginal cavity with 30 µl PBS. Two 30-µl washes 
were taken per mouse per day. Samples were subsequently 
centrifuged at 800  g for 5 min, and supernatants were 
removed for IFN-γ or IL-18 measurement by ELI SA.
In vivo treatments
0.5 µg recombinant mouse IL-15 was incubated with 1 µg 
recombinant mouse IL-15Rα in PBS at 37°C for 30 min. 
Each mouse was administered 0.5 µg IL-15 with 1 µg IL-15 
Rα complex i.p. on day 0. To deplete neutrophils and inflam-
matory monocytes, anti–GR-1 antibody or isotype-matched 
control antibodies were administered i.p. on days −2, −1, and 
1 p.i. To deplete inflammatory monocytes, 10–20 µg anti- 
CCR2 antibody or isotype control antibodies were adminis-
tered i.p. on days −1, 0, 1, and 2 p.i. To block IFN AR in vivo, 
B6 mice were administered 500 µg anti-IFN AR antibody or 
isotype-matched control antibody on days −1, 0, and 1 and 
250 µg of each antibody on days 3 and 5. To deplete NK cells, 
200 µg anti-NK1.1 antibody was given i.p. on days −2 and 
−1 before infection. Anti–IL-15 was generated by E. Butz 
and provided by Amgen. 40 µg anti–IL-15 antibody was then 
given i.p. to mice on day −1 before infection.
cell isolation from tissues
Blood and splenocytes were obtained and processed to a sin-
gle-cell suspension. Red blood cells were removed using ACK 
lysis buffer. Vaginal tissue was isolated, minced, and incubated in 
a digestion mixture of RPMI-1640 with 10% FBS, 1% penicillin 
and streptomycin, 1% l-glutamine, 1% Hepes, and 0.030 mg/ml 
collagenase A for two separate 1-h incubations. Cells were col-
lected after each incubation and passed through a 40-µm filter.
nK cell adoptive transfer
Mouse splenocytes were obtained and processed into 
a single-cell suspension in 2% BSA in PBS before iso-
lation of NK cells. NK cells were isolated using Stem 
Cell EasySep pan-NK cell isolation or EasySep PE 
selection (using PE-conjugated anti-NK1.1) kits with 
magnetic separation. 2 × 106 to 3 × 106 B6, Ifnar−/−, or 
Il18r1−/− NK cells were adoptively transferred i.v. into 
Rag2−/−Il2rg−/− or Ifnar−/− mice.
ex vivo stimulation
WT, Ifnar−/−, and Il18r−/− NK cells were isolated as previously 
described. NK cells were stimulated with 50 ng/ml PMA and 
500 ng/ml ionomycin for 24 h ex vivo. Supernatants were 
collected and assayed for IFN-γ levels.
cytokine detection
IFN-γ in either supernatants or vaginal lavages was detected 
by using DuoSet ELI SA kits (R&D Systems). IL-18 in vaginal 
lavages was detected by using the IL-18 ELI SA from MBL. 
CCL2 in vaginal lavages was detected by using the CCL2 and 
MCP-1 DuoSet ELI SA kit.
Flow cytometry staining
In brief, cells were plated at 106 cells/well in 0.2% BSA in 
PBS. Nonspecific antibody binding was blocked with anti–
CD16+CD32 antibody 2.4G2. Extracellular cell staining was 
conducted by using combinations of Alexa Fluor 700– or PE-
Texas Red–conjugated anti-CD45; Alexa Fluor 700– or PE 
Texas Red–conjugated anti-CD3; PE- or Brilliant Violet 421–
conjugated anti-NK1.1; APC-conjugated DX5 mAb; PerCp- 
conjugated anti-NKp46; PE-Cy-7– or PerCp-Cy5.5–conjugated 
anti-CD11b; FITC-, Alexa Fluor 700–, or APC-conjugated 
anti-F4/80; Alexa Fluor 700–, APC-, PE-, or Pe-Cy-7– 
conjugated anti-CD11c; Brilliant Violet 421– or Alexa Fluor 
700–conjugated anti-GR1; FITC- or BV510-conjugated 
anti-Ly6G; Pacific Blue–conjugated anti-Ly6C; APC-conjugated 
anti-CCR2; and PE-conjugated anti-IFN AR. For intracellu-
lar staining, cells were permeabilized using Cytofix/Cytoperm 
(BD) and then stained with APC-conjugated anti–IFN-γ. Cells 
were fixed in 1% PFA in PBS and run on the FAC SCanto or 
LSR II (BD). Data were analyzed using FlowJo software.
Generation of bone marrow chimeras
Bone marrow was collected from WT, Ifnar−/−, and IL18−/− 
B6 mice and T cell depleted using anti-CD4 (GK1.5, 
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anti-CD8 [2.43], and anti-Thy1.2 [BD] and low-tox guinea 
pig complement [Cedarlane]). Recipient mice were irradi-
ated with two doses of 550 rad with a 3-h interval between 
irradiations and reconstituted with 107 T cell–depleted bone 
marrow cells after the second dose of irradiation.
Statistical analyses
Differences were assessed using Student’s t test (parametric 
data), Mann–Whitney test (nonparametric data), one-way 
ANO VA (if more than two groups were being analyzed), or 
two-way ANO VA (if more than two groups were being an-
alyzed with more than one independent variable). If post- 
statistical analysis was required, a Bonferroni post-test was 
applied. Outliers were determined using the extreme stu-
dentized deviate (ESD) method and removed if deemed a sig-
nificant outlier (0.05). All statistical analyses were completed 
using GraphPad Prism 4.0. Statistical significance is indicated 
as ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; 
or n.s. (not significant).
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